Guangzhou KingMed Diagnostics Medical Laboratory Group Co., Ltd. (hereinafter referred to as "KingMed Diagnostics", stock code: 603882) is one of the early enterprises in the third-party medical laboratory industry in China. Nowadays, it has developed into a leading enterprise with large scale, large number of laboratories, wide market network, well-developed test items and technology platform in the domestic third-party medical laboratory industry. Nanjing KingMed Diagnostics laboratory Co., Ltd., established on May 16, 2007 with a registered capital of 20 million yuan, is a wholly-owned enterprise invested by Guangzhou KingMed Diagnostics Medical Laboratory Group Co., Ltd. The company is located in No.1 Building of Accelerator phase II, No. 11, Yaogu Avenue, Nanjing Jiangbei New Area, with a laboratory area of 5600 square meters, which has been approved by ISO15189 medical laboratory. It is a third-party medical laboratory specialized in medical testing services. It is a biomedical service-oriented enterprise mainly engaged in medical testing, pathological diagnosis, scientific research services and other related testing services. Its business scope covers 13 prefecture level cities in the province. At present, it has provided more than 2300 medical testing services for nearly 900 customers in the province.